Clinical data requirements for Class III medical devices in Taiwan include comprehensive evidence demonstrating safety, efficacy, and performance. Manufacturers must provide results from extensive clinical trials, risk assessments, and post-market surveillance plans. The data must comply with applicable regulations and guidelines, ensuring thorough evaluation by the TFDA before granting market authorization for the device.
